nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—esophageal cancer	0.78	1	CbGaD
Tranylcypromine—Memory loss—Cisplatin—esophageal cancer	0.00314	0.0699	CcSEcCtD
Tranylcypromine—Hypertensive crisis—Capecitabine—esophageal cancer	0.00245	0.0545	CcSEcCtD
Tranylcypromine—Benzyl alcohol—ALDH2—esophageal cancer	0.00179	0.756	CrCbGaD
Tranylcypromine—Inappropriate antidiuretic hormone secretion—Cisplatin—esophageal cancer	0.00159	0.0353	CcSEcCtD
Tranylcypromine—Myoclonus—Capecitabine—esophageal cancer	0.00113	0.0252	CcSEcCtD
Tranylcypromine—Neck stiffness—Methotrexate—esophageal cancer	0.00106	0.0237	CcSEcCtD
Tranylcypromine—Tenderness—Cisplatin—esophageal cancer	0.00106	0.0235	CcSEcCtD
Tranylcypromine—Nuchal rigidity—Methotrexate—esophageal cancer	0.000976	0.0217	CcSEcCtD
Tranylcypromine—Pain—Carboplatin—esophageal cancer	0.00096	0.0214	CcSEcCtD
Tranylcypromine—Body temperature increased—Carboplatin—esophageal cancer	0.000888	0.0197	CcSEcCtD
Tranylcypromine—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.000758	0.0169	CcSEcCtD
Tranylcypromine—Amnesia—Cisplatin—esophageal cancer	0.000713	0.0159	CcSEcCtD
Tranylcypromine—Blood pressure increased—Capecitabine—esophageal cancer	0.00068	0.0151	CcSEcCtD
Tranylcypromine—Urinary incontinence—Capecitabine—esophageal cancer	0.000657	0.0146	CcSEcCtD
Tranylcypromine—Amphetamine—CYP2A6—esophageal cancer	0.000579	0.244	CrCbGaD
Tranylcypromine—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.000565	0.0126	CcSEcCtD
Tranylcypromine—Amnesia—Capecitabine—esophageal cancer	0.000526	0.0117	CcSEcCtD
Tranylcypromine—Bradycardia—Cisplatin—esophageal cancer	0.000472	0.0105	CcSEcCtD
Tranylcypromine—Urinary retention—Capecitabine—esophageal cancer	0.00047	0.0105	CcSEcCtD
Tranylcypromine—Ataxia—Capecitabine—esophageal cancer	0.000464	0.0103	CcSEcCtD
Tranylcypromine—Tinnitus—Cisplatin—esophageal cancer	0.000432	0.00962	CcSEcCtD
Tranylcypromine—Flushing—Cisplatin—esophageal cancer	0.00043	0.00957	CcSEcCtD
Tranylcypromine—Alopecia—Cisplatin—esophageal cancer	0.00041	0.00911	CcSEcCtD
Tranylcypromine—Muscle spasms—Cisplatin—esophageal cancer	0.000388	0.00863	CcSEcCtD
Tranylcypromine—Vision blurred—Cisplatin—esophageal cancer	0.00038	0.00846	CcSEcCtD
Tranylcypromine—Tremor—Cisplatin—esophageal cancer	0.000378	0.00841	CcSEcCtD
Tranylcypromine—Anaemia—Cisplatin—esophageal cancer	0.000373	0.0083	CcSEcCtD
Tranylcypromine—Leukopenia—Cisplatin—esophageal cancer	0.000361	0.00804	CcSEcCtD
Tranylcypromine—Agranulocytosis—Capecitabine—esophageal cancer	0.000355	0.0079	CcSEcCtD
Tranylcypromine—Bradycardia—Capecitabine—esophageal cancer	0.000348	0.00774	CcSEcCtD
Tranylcypromine—Ataxia—Methotrexate—esophageal cancer	0.000346	0.00769	CcSEcCtD
Tranylcypromine—Haemoglobin—Capecitabine—esophageal cancer	0.000343	0.00764	CcSEcCtD
Tranylcypromine—Anxiety—Cisplatin—esophageal cancer	0.000342	0.00762	CcSEcCtD
Tranylcypromine—Hepatitis—Capecitabine—esophageal cancer	0.000342	0.0076	CcSEcCtD
Tranylcypromine—Haemorrhage—Capecitabine—esophageal cancer	0.000342	0.0076	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00034	0.00756	CcSEcCtD
Tranylcypromine—Oedema—Cisplatin—esophageal cancer	0.000329	0.00733	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000322	0.00717	CcSEcCtD
Tranylcypromine—Tachycardia—Cisplatin—esophageal cancer	0.000321	0.00715	CcSEcCtD
Tranylcypromine—Tinnitus—Capecitabine—esophageal cancer	0.000319	0.00709	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000318	0.00708	CcSEcCtD
Tranylcypromine—Flushing—Capecitabine—esophageal cancer	0.000317	0.00706	CcSEcCtD
Tranylcypromine—Anorexia—Cisplatin—esophageal cancer	0.000314	0.00698	CcSEcCtD
Tranylcypromine—Hypotension—Cisplatin—esophageal cancer	0.000308	0.00685	CcSEcCtD
Tranylcypromine—Chills—Capecitabine—esophageal cancer	0.000307	0.00682	CcSEcCtD
Tranylcypromine—Alopecia—Capecitabine—esophageal cancer	0.000302	0.00672	CcSEcCtD
Tranylcypromine—Paraesthesia—Cisplatin—esophageal cancer	0.000296	0.00658	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000293	0.00651	CcSEcCtD
Tranylcypromine—Decreased appetite—Cisplatin—esophageal cancer	0.000286	0.00637	CcSEcCtD
Tranylcypromine—Muscle spasms—Capecitabine—esophageal cancer	0.000286	0.00636	CcSEcCtD
Tranylcypromine—Drowsiness—Methotrexate—esophageal cancer	0.000283	0.0063	CcSEcCtD
Tranylcypromine—Pain—Cisplatin—esophageal cancer	0.000282	0.00627	CcSEcCtD
Tranylcypromine—Vision blurred—Capecitabine—esophageal cancer	0.00028	0.00624	CcSEcCtD
Tranylcypromine—Tremor—Capecitabine—esophageal cancer	0.000279	0.0062	CcSEcCtD
Tranylcypromine—Anaemia—Capecitabine—esophageal cancer	0.000275	0.00612	CcSEcCtD
Tranylcypromine—Sweating—Methotrexate—esophageal cancer	0.000272	0.00604	CcSEcCtD
Tranylcypromine—Feeling abnormal—Cisplatin—esophageal cancer	0.000271	0.00604	CcSEcCtD
Tranylcypromine—Syncope—Capecitabine—esophageal cancer	0.000267	0.00594	CcSEcCtD
Tranylcypromine—Leukopenia—Capecitabine—esophageal cancer	0.000266	0.00592	CcSEcCtD
Tranylcypromine—Agranulocytosis—Methotrexate—esophageal cancer	0.000264	0.00588	CcSEcCtD
Tranylcypromine—Palpitations—Capecitabine—esophageal cancer	0.000263	0.00585	CcSEcCtD
Tranylcypromine—Loss of consciousness—Capecitabine—esophageal cancer	0.000261	0.00582	CcSEcCtD
Tranylcypromine—Body temperature increased—Cisplatin—esophageal cancer	0.00026	0.00579	CcSEcCtD
Tranylcypromine—Hypertension—Capecitabine—esophageal cancer	0.000257	0.00571	CcSEcCtD
Tranylcypromine—Haemoglobin—Methotrexate—esophageal cancer	0.000256	0.00569	CcSEcCtD
Tranylcypromine—Haemorrhage—Methotrexate—esophageal cancer	0.000254	0.00566	CcSEcCtD
Tranylcypromine—Hepatitis—Methotrexate—esophageal cancer	0.000254	0.00566	CcSEcCtD
Tranylcypromine—Anxiety—Capecitabine—esophageal cancer	0.000252	0.00562	CcSEcCtD
Tranylcypromine—Dry mouth—Capecitabine—esophageal cancer	0.000248	0.00551	CcSEcCtD
Tranylcypromine—Confusional state—Capecitabine—esophageal cancer	0.000245	0.00545	CcSEcCtD
Tranylcypromine—Oedema—Capecitabine—esophageal cancer	0.000243	0.0054	CcSEcCtD
Tranylcypromine—Shock—Capecitabine—esophageal cancer	0.000239	0.00531	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000238	0.00529	CcSEcCtD
Tranylcypromine—Tinnitus—Methotrexate—esophageal cancer	0.000237	0.00528	CcSEcCtD
Tranylcypromine—Tachycardia—Capecitabine—esophageal cancer	0.000237	0.00527	CcSEcCtD
Tranylcypromine—Asthenia—Cisplatin—esophageal cancer	0.000236	0.00526	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000235	0.00522	CcSEcCtD
Tranylcypromine—Anorexia—Capecitabine—esophageal cancer	0.000231	0.00515	CcSEcCtD
Tranylcypromine—Chills—Methotrexate—esophageal cancer	0.000228	0.00508	CcSEcCtD
Tranylcypromine—Hypotension—Capecitabine—esophageal cancer	0.000227	0.00505	CcSEcCtD
Tranylcypromine—Diarrhoea—Cisplatin—esophageal cancer	0.000225	0.00501	CcSEcCtD
Tranylcypromine—Alopecia—Methotrexate—esophageal cancer	0.000225	0.005	CcSEcCtD
Tranylcypromine—Insomnia—Capecitabine—esophageal cancer	0.00022	0.00489	CcSEcCtD
Tranylcypromine—Paraesthesia—Capecitabine—esophageal cancer	0.000218	0.00485	CcSEcCtD
Tranylcypromine—Decreased appetite—Capecitabine—esophageal cancer	0.000211	0.0047	CcSEcCtD
Tranylcypromine—Vomiting—Cisplatin—esophageal cancer	0.000209	0.00466	CcSEcCtD
Tranylcypromine—Vision blurred—Methotrexate—esophageal cancer	0.000209	0.00464	CcSEcCtD
Tranylcypromine—Rash—Cisplatin—esophageal cancer	0.000208	0.00462	CcSEcCtD
Tranylcypromine—Constipation—Capecitabine—esophageal cancer	0.000208	0.00462	CcSEcCtD
Tranylcypromine—Pain—Capecitabine—esophageal cancer	0.000208	0.00462	CcSEcCtD
Tranylcypromine—Dermatitis—Cisplatin—esophageal cancer	0.000207	0.00462	CcSEcCtD
Tranylcypromine—Anaemia—Methotrexate—esophageal cancer	0.000205	0.00455	CcSEcCtD
Tranylcypromine—Feeling abnormal—Capecitabine—esophageal cancer	0.0002	0.00445	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000199	0.00442	CcSEcCtD
Tranylcypromine—Leukopenia—Methotrexate—esophageal cancer	0.000198	0.00441	CcSEcCtD
Tranylcypromine—Nausea—Cisplatin—esophageal cancer	0.000196	0.00435	CcSEcCtD
Tranylcypromine—Urticaria—Capecitabine—esophageal cancer	0.000193	0.00429	CcSEcCtD
Tranylcypromine—Abdominal pain—Capecitabine—esophageal cancer	0.000192	0.00427	CcSEcCtD
Tranylcypromine—Body temperature increased—Capecitabine—esophageal cancer	0.000192	0.00427	CcSEcCtD
Tranylcypromine—Confusional state—Methotrexate—esophageal cancer	0.000182	0.00405	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000177	0.00394	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000175	0.00389	CcSEcCtD
Tranylcypromine—Asthenia—Capecitabine—esophageal cancer	0.000174	0.00388	CcSEcCtD
Tranylcypromine—Anorexia—Methotrexate—esophageal cancer	0.000172	0.00383	CcSEcCtD
Tranylcypromine—Hypotension—Methotrexate—esophageal cancer	0.000169	0.00376	CcSEcCtD
Tranylcypromine—Diarrhoea—Capecitabine—esophageal cancer	0.000166	0.0037	CcSEcCtD
Tranylcypromine—Insomnia—Methotrexate—esophageal cancer	0.000163	0.00364	CcSEcCtD
Tranylcypromine—Paraesthesia—Methotrexate—esophageal cancer	0.000162	0.00361	CcSEcCtD
Tranylcypromine—Somnolence—Methotrexate—esophageal cancer	0.000161	0.00357	CcSEcCtD
Tranylcypromine—Dizziness—Capecitabine—esophageal cancer	0.000161	0.00357	CcSEcCtD
Tranylcypromine—Decreased appetite—Methotrexate—esophageal cancer	0.000157	0.0035	CcSEcCtD
Tranylcypromine—Pain—Methotrexate—esophageal cancer	0.000155	0.00344	CcSEcCtD
Tranylcypromine—Vomiting—Capecitabine—esophageal cancer	0.000154	0.00343	CcSEcCtD
Tranylcypromine—Rash—Capecitabine—esophageal cancer	0.000153	0.00341	CcSEcCtD
Tranylcypromine—Dermatitis—Capecitabine—esophageal cancer	0.000153	0.0034	CcSEcCtD
Tranylcypromine—Headache—Capecitabine—esophageal cancer	0.000152	0.00338	CcSEcCtD
Tranylcypromine—Feeling abnormal—Methotrexate—esophageal cancer	0.000149	0.00331	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000148	0.00329	CcSEcCtD
Tranylcypromine—Nausea—Capecitabine—esophageal cancer	0.000144	0.00321	CcSEcCtD
Tranylcypromine—Urticaria—Methotrexate—esophageal cancer	0.000144	0.00319	CcSEcCtD
Tranylcypromine—Abdominal pain—Methotrexate—esophageal cancer	0.000143	0.00318	CcSEcCtD
Tranylcypromine—Body temperature increased—Methotrexate—esophageal cancer	0.000143	0.00318	CcSEcCtD
Tranylcypromine—Asthenia—Methotrexate—esophageal cancer	0.00013	0.00289	CcSEcCtD
Tranylcypromine—Diarrhoea—Methotrexate—esophageal cancer	0.000124	0.00275	CcSEcCtD
Tranylcypromine—Dizziness—Methotrexate—esophageal cancer	0.00012	0.00266	CcSEcCtD
Tranylcypromine—Vomiting—Methotrexate—esophageal cancer	0.000115	0.00256	CcSEcCtD
Tranylcypromine—Rash—Methotrexate—esophageal cancer	0.000114	0.00254	CcSEcCtD
Tranylcypromine—Dermatitis—Methotrexate—esophageal cancer	0.000114	0.00253	CcSEcCtD
Tranylcypromine—Headache—Methotrexate—esophageal cancer	0.000113	0.00252	CcSEcCtD
Tranylcypromine—Nausea—Methotrexate—esophageal cancer	0.000107	0.00239	CcSEcCtD
Tranylcypromine—CYP2C9—Metabolism—BLVRB—esophageal cancer	4.05e-05	0.000234	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC52A3—esophageal cancer	4.05e-05	0.000234	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—TPI1—esophageal cancer	3.99e-05	0.000231	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTO1—esophageal cancer	3.99e-05	0.000231	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTT1—esophageal cancer	3.99e-05	0.000231	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.97e-05	0.00023	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP2A6—esophageal cancer	3.94e-05	0.000228	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.9e-05	0.000225	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ALDOB—esophageal cancer	3.83e-05	0.000221	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SLC10A2—esophageal cancer	3.78e-05	0.000219	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CA1—esophageal cancer	3.78e-05	0.000219	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS1—esophageal cancer	3.74e-05	0.000216	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ENO1—esophageal cancer	3.74e-05	0.000216	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GAPDH—esophageal cancer	3.69e-05	0.000213	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PSME2—esophageal cancer	3.68e-05	0.000213	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PSME1—esophageal cancer	3.68e-05	0.000213	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CRABP1—esophageal cancer	3.65e-05	0.000211	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ADH1B—esophageal cancer	3.65e-05	0.000211	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.62e-05	0.00021	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—TYMP—esophageal cancer	3.49e-05	0.000202	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CA1—esophageal cancer	3.48e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	3.48e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GNG7—esophageal cancer	3.47e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—BLVRB—esophageal cancer	3.46e-05	0.0002	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC52A3—esophageal cancer	3.46e-05	0.0002	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CA2—esophageal cancer	3.46e-05	0.0002	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CA1—esophageal cancer	3.45e-05	0.000199	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC10A2—esophageal cancer	3.45e-05	0.000199	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP26A1—esophageal cancer	3.4e-05	0.000196	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.38e-05	0.000195	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ALOX15—esophageal cancer	3.31e-05	0.000191	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ALDH2—esophageal cancer	3.26e-05	0.000188	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PLCE1—esophageal cancer	3.21e-05	0.000186	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ADH7—esophageal cancer	3.21e-05	0.000186	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CA2—esophageal cancer	3.18e-05	0.000184	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP1B1—esophageal cancer	3.18e-05	0.000184	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.18e-05	0.000184	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTO1—esophageal cancer	3.16e-05	0.000183	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—TPI1—esophageal cancer	3.16e-05	0.000183	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CA2—esophageal cancer	3.15e-05	0.000182	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTT1—esophageal cancer	3.1e-05	0.000179	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.1e-05	0.000179	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.08e-05	0.000178	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ALDOB—esophageal cancer	3.03e-05	0.000175	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP19A1—esophageal cancer	2.99e-05	0.000173	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ADH7—esophageal cancer	2.96e-05	0.000171	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PLCE1—esophageal cancer	2.96e-05	0.000171	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC10A2—esophageal cancer	2.94e-05	0.00017	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CA1—esophageal cancer	2.94e-05	0.00017	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.93e-05	0.000169	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ADH7—esophageal cancer	2.93e-05	0.000169	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GAPDH—esophageal cancer	2.91e-05	0.000168	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ENO1—esophageal cancer	2.9e-05	0.000168	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS1—esophageal cancer	2.9e-05	0.000168	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.9e-05	0.000168	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CRABP1—esophageal cancer	2.89e-05	0.000167	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PSME1—esophageal cancer	2.86e-05	0.000165	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PSME2—esophageal cancer	2.86e-05	0.000165	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.82e-05	0.000163	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CREBBP—esophageal cancer	2.79e-05	0.000161	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GNG7—esophageal cancer	2.75e-05	0.000159	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—HMOX1—esophageal cancer	2.73e-05	0.000158	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CA2—esophageal cancer	2.69e-05	0.000156	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TYMP—esophageal cancer	2.69e-05	0.000156	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.67e-05	0.000155	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.67e-05	0.000155	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.63e-05	0.000152	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.62e-05	0.000152	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ABCB1—esophageal cancer	2.62e-05	0.000151	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.59e-05	0.00015	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ALDH2—esophageal cancer	2.57e-05	0.000149	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.57e-05	0.000149	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.55e-05	0.000148	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ADH7—esophageal cancer	2.5e-05	0.000145	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.5e-05	0.000145	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—NOS3—esophageal cancer	2.5e-05	0.000144	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TYMP—esophageal cancer	2.48e-05	0.000143	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.47e-05	0.000143	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP1B1—esophageal cancer	2.47e-05	0.000143	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TYMP—esophageal cancer	2.46e-05	0.000142	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTT1—esophageal cancer	2.45e-05	0.000142	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TPI1—esophageal cancer	2.44e-05	0.000141	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.44e-05	0.000141	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP2A6—esophageal cancer	2.42e-05	0.00014	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.41e-05	0.000139	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.39e-05	0.000138	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.35e-05	0.000136	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALDOB—esophageal cancer	2.33e-05	0.000135	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.33e-05	0.000135	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP19A1—esophageal cancer	2.32e-05	0.000134	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ENO1—esophageal cancer	2.29e-05	0.000133	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS1—esophageal cancer	2.29e-05	0.000133	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTGS2—esophageal cancer	2.28e-05	0.000132	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CA1—esophageal cancer	2.27e-05	0.000131	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.27e-05	0.000131	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PSME2—esophageal cancer	2.26e-05	0.000131	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PSME1—esophageal cancer	2.26e-05	0.000131	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GAPDH—esophageal cancer	2.25e-05	0.00013	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TPI1—esophageal cancer	2.24e-05	0.00013	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.24e-05	0.00013	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CRABP1—esophageal cancer	2.23e-05	0.000129	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TPI1—esophageal cancer	2.22e-05	0.000128	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.22e-05	0.000128	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.2e-05	0.000127	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.15e-05	0.000124	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.13e-05	0.000123	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GNG7—esophageal cancer	2.12e-05	0.000123	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—HMOX1—esophageal cancer	2.12e-05	0.000122	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TYMP—esophageal cancer	2.1e-05	0.000121	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CA2—esophageal cancer	2.08e-05	0.00012	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.07e-05	0.00012	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.05e-05	0.000119	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CRABP1—esophageal cancer	2.05e-05	0.000118	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.04e-05	0.000118	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ABCB1—esophageal cancer	2.03e-05	0.000118	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.03e-05	0.000117	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.99e-05	0.000115	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.99e-05	0.000115	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP1B1—esophageal cancer	1.95e-05	0.000113	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GNG7—esophageal cancer	1.95e-05	0.000113	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ADH7—esophageal cancer	1.93e-05	0.000112	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.93e-05	0.000112	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GNG7—esophageal cancer	1.93e-05	0.000112	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—EP300—esophageal cancer	1.9e-05	0.00011	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.9e-05	0.00011	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TPI1—esophageal cancer	1.9e-05	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.89e-05	0.000109	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.87e-05	0.000108	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.86e-05	0.000108	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.83e-05	0.000106	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.83e-05	0.000106	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.82e-05	0.000105	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.81e-05	0.000105	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ENO1—esophageal cancer	1.77e-05	0.000102	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.77e-05	0.000102	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.75e-05	0.000101	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CREBBP—esophageal cancer	1.75e-05	0.000101	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PSME1—esophageal cancer	1.74e-05	0.000101	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PSME2—esophageal cancer	1.74e-05	0.000101	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.74e-05	0.0001	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.74e-05	0.0001	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.72e-05	9.96e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.72e-05	9.93e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.7e-05	9.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.7e-05	9.81e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.69e-05	9.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.67e-05	9.68e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GNG7—esophageal cancer	1.65e-05	9.55e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ENO1—esophageal cancer	1.63e-05	9.41e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.63e-05	9.41e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TYMP—esophageal cancer	1.62e-05	9.37e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.61e-05	9.33e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ENO1—esophageal cancer	1.61e-05	9.33e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ABCB1—esophageal cancer	1.61e-05	9.29e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PSME2—esophageal cancer	1.6e-05	9.28e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PSME1—esophageal cancer	1.6e-05	9.28e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PSME2—esophageal cancer	1.59e-05	9.19e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PSME1—esophageal cancer	1.59e-05	9.19e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.58e-05	9.11e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NOS3—esophageal cancer	1.57e-05	9.06e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.55e-05	8.95e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.54e-05	8.88e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.52e-05	8.81e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.5e-05	8.7e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.47e-05	8.51e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TPI1—esophageal cancer	1.46e-05	8.47e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.46e-05	8.47e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.45e-05	8.41e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.45e-05	8.38e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS2—esophageal cancer	1.43e-05	8.29e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.41e-05	8.18e-05	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PIK3CA—esophageal cancer	1.4e-05	8.12e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.4e-05	8.12e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.39e-05	8.03e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.38e-05	8e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ENO1—esophageal cancer	1.38e-05	7.97e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.38e-05	7.97e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.37e-05	7.93e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PSME1—esophageal cancer	1.36e-05	7.86e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PSME2—esophageal cancer	1.36e-05	7.86e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CREBBP—esophageal cancer	1.36e-05	7.85e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.35e-05	7.82e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.34e-05	7.75e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.3e-05	7.52e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.29e-05	7.47e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.29e-05	7.46e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GNG7—esophageal cancer	1.27e-05	7.37e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.27e-05	7.32e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.24e-05	7.17e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NOS3—esophageal cancer	1.22e-05	7.03e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.19e-05	6.9e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—EP300—esophageal cancer	1.19e-05	6.89e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.19e-05	6.87e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.19e-05	6.86e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.18e-05	6.81e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.17e-05	6.78e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.15e-05	6.68e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.14e-05	6.59e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.14e-05	6.57e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.13e-05	6.53e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.12e-05	6.49e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS2—esophageal cancer	1.11e-05	6.43e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.1e-05	6.37e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CREBBP—esophageal cancer	1.07e-05	6.21e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.06e-05	6.15e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.06e-05	6.15e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.05e-05	6.06e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.05e-05	6.06e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.01e-05	5.82e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.87e-06	5.71e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ABCB1—esophageal cancer	9.65e-06	5.58e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NOS3—esophageal cancer	9.61e-06	5.56e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.37e-06	5.42e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—EP300—esophageal cancer	9.25e-06	5.35e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.05e-06	5.23e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CA—esophageal cancer	8.81e-06	5.1e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS2—esophageal cancer	8.79e-06	5.08e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.54e-06	4.94e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.51e-06	4.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CREBBP—esophageal cancer	8.28e-06	4.79e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.76e-06	4.49e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CREBBP—esophageal cancer	7.62e-06	4.4e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CREBBP—esophageal cancer	7.55e-06	4.37e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.45e-06	4.31e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NOS3—esophageal cancer	7.41e-06	4.29e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—EP300—esophageal cancer	7.31e-06	4.23e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.3e-06	4.22e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CA—esophageal cancer	6.84e-06	3.96e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NOS3—esophageal cancer	6.82e-06	3.94e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS2—esophageal cancer	6.78e-06	3.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NOS3—esophageal cancer	6.76e-06	3.91e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.45e-06	3.73e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS2—esophageal cancer	6.24e-06	3.61e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS2—esophageal cancer	6.18e-06	3.58e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NOS3—esophageal cancer	5.78e-06	3.34e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—EP300—esophageal cancer	5.64e-06	3.26e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	5.41e-06	3.13e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.28e-06	3.06e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—EP300—esophageal cancer	5.19e-06	3e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—EP300—esophageal cancer	5.14e-06	2.97e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.98e-06	2.88e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NOS3—esophageal cancer	4.46e-06	2.58e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—EP300—esophageal cancer	4.39e-06	2.54e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	4.17e-06	2.41e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.08e-06	2.36e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.84e-06	2.22e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.8e-06	2.2e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—EP300—esophageal cancer	3.39e-06	1.96e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.25e-06	1.88e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.51e-06	1.45e-05	CbGpPWpGaD
